Fortress Biotech, Inc.(NASDAQ : FBIO)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||0.26%||7.68||0.7%||$536.86m|
|GILD||Gilead Sciences, Inc.||-0.55%||68.53||1.0%||$504.56m|
|REGN||Regeneron Pharmaceuticals, Inc.||-0.11%||516.62||2.7%||$432.65m|
|ALXN||Alexion Pharmaceuticals, Inc.||0.09%||173.49||2.0%||$412.31m|
|VRTX||Vertex Pharmaceuticals, Inc.||1.28%||217.09||1.9%||$311.54m|
|CRSP||CRISPR Therapeutics AG||5.58%||106.64||0.6%||$171.41m|
|BNGO||Bionano Genomics, Inc.||22.45%||5.40||0.0%||$162.77m|
Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the following Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded on June 28, 2006 and is headquartered in New York, NY.